Scientists at the MD Anderson Cancer Center at The University of Texas have developed a new blood test that in combination with a risk model based on smoking history, helps predict who may benefit from lung cancer screening, more accurately than current guidelines. The researchers show the combined personalized risk assessment would have identified 105 of 119 people in the PLCO Cancer Screening Trial, who received a lung cancer diagnosis within one year.